CONNECT WITH US
HealthTech

HealthTech

STAT+: Why this startup is taking its AI to predict breast cancer risk directly to patients

STAT — Health Tech logo

Published on

Add as a preferred source on Google
STAT+: Why this startup is taking its AI to predict breast cancer risk directly to patients

That’s the call to action that patients will find on the site for digital health company Everlywell, which has offered at-home lab tests directly to consumers for a decade. But last week, it wasn’t marketing a prick to measure blood glucose or screen for celiac disease: It was launching one of a new generation of AI-based risk prediction algorithms for medical images. 

For $249 in cash, eligible patients can now come to the site, share a recent mammogram, and receive a prediction of their five-year breast cancer risk. It’s generated by an AI algorithm called Clairity Breast, which received de novo authorization from the Food and Drug Administration last May. 



Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.